Pinnacle Financial Group, Inc.’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
Other funds holding NKTR
Pinnacle Financial Group, Inc.'s NKTR Position: Q3 2026 in Review
Pinnacle Financial Group, Inc. opened a new position in Nektar Therapeutics (NKTR) in Q3 2026: 30 shares worth $1.82K. The stake represents ﹤0.01% of the portfolio and ranks #2007 among its holdings.
243 funds tracked by Wall St. Rank hold NKTR as of Q3 2026.
- Pinnacle Financial Group, Inc. held 30 shares of Nektar Therapeutics worth $1.82K as of Q3 2026.
- Nektar Therapeutics was a new Pinnacle Financial Group, Inc. position in Q3 2026.
- Nektar Therapeutics made up ﹤0.01% of Pinnacle Financial Group, Inc.'s portfolio in Q3 2026, its #2007 holding.
- 243 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2026.
Based on Pinnacle Financial Group, Inc.'s 13F filing for Q3 2026, filed 16 Nov 2026.